Featured content

blue DNA sequence banner

Outlook

Biopharma and medtech investments end 2024 on a high note

Jan 09, 2025

Our Biopharma and Medtech Licensing and Venture Reports explore upfront cash, mergers, acquisitions and other trends seen in the fourth quarter of 2024.

Read more
  • Sort by content type

    • Select an option

    • Client Story

    • Insight

    • Video

List View Off List View On

    No results found

    Adjust your filter selections to find what you’re looking for

    Contact us

    By checking the box below I consent to JPMorgan Chase using the information I have provided to send me:

    Learn more about our data practices in our privacy policy.